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Abstract:  Marine  ecosystems  (>70%  of  the  planet's  surface)  comprise  a  continuous 
resource  of  immeasurable  biological  activities  and  immense  chemical  entities.  This 
diversity has provided a unique source of chemical compounds with potential bioactivities 
that could lead to potential new drug candidates. Many marine-living organisms are soft 
bodied and/or sessile. Consequently, they have developed toxic secondary metabolites or 
obtained them from microorganisms to defend themselves against predators [1]. For the 
last 30–40 years, marine invertebrates have been an attractive research topic for scientists 
all over the world. A relatively small number of marine plants, animals and microbes have 
yielded more than 15,000 natural products including numerous compounds with potential 
pharmaceutical potential. Some of these have already been launched on the pharmaceutical 
market  such  as  Prialt
®  (ziconotide;  potent  analgesic)  and  Yondelis
®  (trabectedin  or  
ET-743; antitumor) while others have entered clinical trials, e.g., alpidin and kahalalide F. 
Amongst the vast array of marine natural products, the terpenoids are one of the more 
commonly reported and discovered to date. Sesterterpenoids (C25) and triterpenoids (C30) 
are  of  frequent  occurrence,  particularly  in  marine  sponges,  and  they  show  prominent 
bioactivities. In this review, we survey sesterterpenoids and triterpenoids obtained from 
marine sponges and highlight their bioactivities. 
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1. Introduction 
Terpenes  include  primary  and  secondary  metabolites,  all  biosynthesized  from  the  five  carbon 
isoprene building units [2]. Structural modification of these isoprene units leads a massively diverse 
range of derivatives with a wide array of chemical structures and biological properties. While higher 
plants’ terpenoids were already studied and ethnopharmacologically rationalized centuries ago, those 
from marine counterparts were not explored until the first half of the 20
th century.  
Steroidal  terpenoids  were  the  first  marine  isoprenes  to  be  discovered  by  Bergmann  during  the 
1930s-1940s,  particularly  sterols  that  were  obtained  from  various  marine  macroorganisms  [3]. 
Secondary metabolites, including terpenes, play an important ecological role in marine organisms. 
Being sessile and soft bodied, marine organisms face a harsh competition for space, reproduction, 
maintenance of an unfouled surface and deterrence of predation [4]. Therefore, marine organisms have 
developed bioactive secondary metabolites as a potential defensive means against competitors and/or 
predators [1]. These compounds are rapidly diluted after being released into the water and hence have 
to  be  of  outstanding  potency  to  retain  their  efficacy.  These  bioactivity(ies)  proved  appealing  for 
chemical ecologists as well as for pharmacologists in their search for new drugs to treat or cure serious 
ailments such as inflammatory, infectious and cancerous diseases. 
Marine terpenoids dominate much of the literature expression with a huge number of derivatives 
having been obtained from marine resources. It seems pointless to compile a review that includes all 
major classes of marine terpenoids. Therefore, in this review we concentrate on two major classes of 
marine  isoprenes  from  sponges,  namely  the  sesterterpenoids  (C25)  and  triterpenoids  (C30)  with 
particular attention placed on their biological activities. 
Marine triterpenoids were the first terpenoids reported from marine resources and since then a vast 
array  of  derivatives  have  been  documented.  In  this  review,  we  cover  steroidal  saponins  and 
isomalabaricane triterpenoids. In addition, marine sponges have been identified as one of the prime 
resources of sesterterpenes and hence we also survey this class of marine terpenoids. 
2. Sesterterpenes (C25) 
Manoalide (1) is the parent compound of a series of marine sponge metabolites belonging to the 
sesterterpene  class.  Manoalide  was  first  reported  in  1980  by  Scheuer  from  the  marine  sponge 
Luffariella  variabilis  (class  Demospongiae;  order  Dictyoceratida;  family  Thorectidae)  collected  in 
Palau [5] with activity as an antibiotic against Streptomyces pyogenes and Staphylococcus aureus. 
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One year later, Scheuer reported three additional related metabolites from the same Palauan sponge, 
namely secomanoalide (2), (E)-neomanoalide (3) and (Z)-neomanoalide (4) [6]. All three compounds, 
as well as the parent compound (1), displayed antibacterial activity against Gram positive bacteria 
(Staphylococcus aureus and Bacillus subtilis) but were inactive against Escherichia coli, Pseudomonas 
aeruginosa and Candida albicans [6]. 
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Later,  marine  sponges  belonging  to  the  family  Thorectidae,  including  species  of  the  genera 
Luffariella [7–19], Hyrtios [20,21], Thorectandra [22], Cacospongia [23,24], Fasciospongia [25–28], 
Acanthodendrilla [29] and Aplysinopsis [30], were also found to be rich sources of novel bioactive 
sesterterpenoids related to manoalide.  
Manoalide was further investigated and found to be a potent inhibitor of phospholipase A2 (PLA2) 
[31–38]. Subsequently, many structurally related metabolites with PLA2 inhibitory activity were also 
reported [8, 39–45]. PLA2 is an enzyme that specifically catalyzes the hydrolysis of phospholipids at 
the SN-2 position to produce a lysophospholipid and arachidonic acid, which in turn provides the 
substrate  for  proinflammatory  mediators  such  as  leukotrienes,  prostaglandins  and  thromboxanes, 
collectively  known as the eicosanoids [41]. Since manoalide revealed an irreversible inhibition of 
phospholipase A2 (PLA2) [33], the structure-activity relationships (SAR) of this compound attracted 
scientific interests to study and to understand both PLA2 function and mechanism of action in the 
whole cell. Therefore, several studies were successfully performed to determine the contributions of 
the  various  functional  groups  incorporated  in  1  and  its  analogs,  such  as  the  γ-hydroxybutenolide,  
α-hydroxydihydropyran and trimethylcyclohexenyl ring systems, to the efficacy as PLA2 inhibitors 
[36,41,45].  These  studies  indicated  that  (1)  the  existence  of  the  hemiacetal  in  the  
α-hydroxydihydropyran ring is crucial for irreversible binding,  (2) the γ-hydroxybutenolide ring is 
involved  in  the  initial  interaction  with  PLA2  and  (3)  the  hydrophobic  nature  of  the 
trimethylcyclohexenyl ring system allows non-bonded interactions with the enzyme that enhances the 
potency  of  these  analogs.  These  studies  suggested  that  the  closed  ring  form  of  manoalide  is  the 
predominant molecular moiety that accounts for the selective and potent inhibition of PLA2 [36]. 
Manoalide  analogs  also  exhibited  other  bioactivities  including  molluscicidal  [10],  cytotoxicity 
[13,14,16,20,23,26,29,30,47–49], inhibitory activity of Cdc25 phosphatase [46], nicotinic antagonistic 
activity [12] and fish deterrent properties [26,49]. Therefore, chemical synthesis and derivatization of 
manoalide  attracted  much  interest  leading  to  a  better  understanding  of  the  structure  activity 
relationships (SAR) and/or for the plausible mechanism of action [35,38–40,43,44,50,51]. Manoalide 
(1)  was  licensed  to  Allergan  Pharmaceuticals  and  reached  phase  II  clinical  trials  as  a  topical 
antipsoriatic.  Its  development  was,  however,  discontinued  due  to  formulation  problems.  The Mar. Drugs 2010, 8     
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compound  is  now  commercially  available  as  a  biochemical  standard  tool  to  block  the  action  of  
PLA2 [52].  
Luffariellolide (5) is a sesterterpenoid analog of secomanoalide (2), which was first reported from a 
Palauan sponge Luffariella sp. [8]. Structurally, luffariellolide differed in having C-24 as methyl group 
instead of an aldehyde functionality as in 2 and it was obtained as the (Z) isomer as well. 
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In contrast to the irreversible inhibitory action of manoalide (1) towards PLA2, luffariellolide (5) is 
a slightly less potent, but a partially reversible inhibitor. This meant that 5 became a more preferable 
anti-inflammatory agent for potential pharmacological investigation [8]. 
In addition to luffariellolide (5), its 25-O-methyl (6) and 25-O-ethyl derivatives (7), five related 
sesterterpenes,  acantholides  A–E, were  obtained from the Indonesian sponge  Acanthodendrilla sp. 
[29]. Acantholide D (8) and E (9) represent rare variants for the C14–C20 segment in this type of linear 
sesterterpenes  in  which  they  have  the  1-acetylcyclopentan-5-ol  moiety  replacing  the 
trimethylcyclohexenyl  ring.  Luffariellolide  (5)  and  its  25-O-methyl  congener  (6),  as  well  as 
acantholide E (9), were cytotoxic against the mouse lymphoma L5178Y cell line with IC50 values of 
8.5, 1.8, and 16.8 µ M, respectively. Interestingly, these results suggest that the 25-O-methyl group in 6 
and the stereochemistry of 1-acetylcyclopentan-5-ol in 9 play an important role [29]. 
Luffariolides A–J represent a related group of sesterterpenoidal analogs, which have been obtained 
from different collections of the Okinawan marine sponge Luffariella sp. [13,14,16]. 
All luffariolides exhibited significant cytotoxicity against murine lymphoma L1210 cells with IC50 
values  ranging  between  2.9–19.3  µ M.  Amongst  them,  luffariolides  A  (10,  IC50  2.9  µ M),  B  (11,  
IC50 3.23 µ M), E (12, IC50 3.0 µ M) and F (13, IC50 3.8 µ M) were the most active ones [13,14,16]. 
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Luffariellins A (14) and B (15) [7] together with their respective 25-acetoxy derivatives (18 and 19) 
[18] were isolated from the marine sponge Luffariella variabilis collected off different locations in 
Palau and in Australia, whereas luffariellins C (16) and D (17) were obtained from the shell-less 
marine mollusc Chromodoris funerea collected from the Kaibakku lake shores in Palau [53].  
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Luffariellins (14–19) are all characterized by the 1-isoproprenyl-2-methylcyclopentane ring system 
replacing the trimethylcyclohexenyl moiety in other manoalide analogs. Despite this discrepancy in 
chemical structure, luffariellins A (14) and B (15) retain identical functional groups as present in 
manoalide (1) and secomanoalide (2), respectively. Therefore, not surprisingly each respective pair 
was shown to have similar anti-inflammatory properties to 1 and 2 [7]. 
Luffarin metabolites comprise another group of compounds represented by 28 derivatives. 26 of 
them, luffarins A–Z, have been reported from the Australian marine sponge Luffariella geometrica 
[12], while the other two were obtained from the Adriatic Sea sponge Fasciospongia cavernosa [28]. 
Based  on  the  chemical  structures,  luffarins  have  been  classified  into  14  bicyclic  sesterterpenes, 
luffarins A–N; one bicyclic bisnorsesterterpene, luffarin O; one monocyclic sesterterpene, luffarin P; 
and  six  acyclic  sesterterpenes,  luffarin  Q–V,  in  addition  to  four  diterpenoidal  derivatives,  
luffarin W–Z [12]. 
All luffarins were tested for antimicrobial activity against Staphylococcus aureus, Micrococcus sp., 
and Saccharomyces cerevisiae. Only luffarins C–F (22–25), K (26) and L (27) showed activity against 
both S. aureus and Micrococcus sp. [12], whereas luffarins A (20) and M (28) revealed only mild 
activity  against  the  latter.  Moreover,  some  luffarins  were  also  found  to  be  effective  inhibitors  of 
nicotinic receptors [12]. 
Biosynthetically, a relationship could be recognized between the various luffarins as illustrated in 
Figure 1. Luffarins appear to belong to the same enantiomeric series as reported for manoalide-type 
marine  natural  products.  It  is  also  curious  to  note  that  no  acyclic  luffarins  incorporated  the Mar. Drugs 2010, 8     
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hydroxylated butenolide functionality. Perhaps the most interesting luffarins from a biosynthetic point 
of  view  are  luffarins  B  (21)  and  O  (21a),  which  were  the  first  examples  of  a  hitherto  unknown 
cyclization pattern in compounds of this class [12]. 
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Figure 1. Postulated biosynthetic relationship between all known Luffariella metabolites [12]. 
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Another example of bicyclic sesterterpenes are thorectandrols A–E (31–35) that were isolated from 
a  Palauan  collection  of  the  marine  sponge  Thorectandra  sp.  [47,48]  together  with  the  parent 
compounds of this group palauolide (29) and palauolol (30). Palauolide (29) was obtained first as an 
antimicrobial sesterterpene from a three sponge association collected in Palau [54]. While palauolol 
(30) was identified as an anti-inflammatory sesterterpene from the Palauan sponge Fascaplysinopsis 
sp.  and  chemically  it  was  recognized  as  being  a  secondary  alcohol  that  upon  dehydration  
yields 29 [55]. 
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All  thorectandrols  (31–35)  in  addition  to  palauolide  (29)  and  palauolol  (30)  were  tested  for 
antiproliferative activity against six to twelve human tumor cell lines depending on sample availability 
[48]. Palauolol (30) was active against all tested cell lines except A549 (non small lung cancer), with 
IC50 values in the range 1.2–1.7 µ M, while palauolide (29) showed a diminished activity. On the other 
hand, thorectandrols A–E revealed only weak to no cytotoxicity against the tested cell lines (IC50’s  
70–100 µ M). While firm deductions on the structural requirements for activity were not possible, it 
appeared that the presence of both the hemiacetal lactone functionality and the 16-hydroxyl group in 
palauolol (30) enhanced cytotoxicity compared to palauolide (29) and other thorectandrols [48]. 
Cacospongionolides  (36–40)  were  isolated  from  different  collections  of  the  marine  sponge 
Fasciospongia  cavernosa  (=Cacospongia  mollior)  collected  from  the  Mediterranean  Sea 
[23,26,49,56]. Cacospongionolides A (36), B (37) and its 25-deoxy derivative (38) revealed a bicyclic 
sesterterpenoidal  skeleton,  resembling  luffarins  and  thorectandrols,  with  the  addition  of  a  
γ-hydroxybutenolide moiety. The other cacospongionolides C (39) and D (40) are acyclic diterpenoidal 
derivatives.  Despite  the  structural  relation  with  luffarins  and  thorectandrols,  cacospongionolides  Mar. Drugs 2010, 8     
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(36–38) together with cacospongionolide D (40) exhibited significant cytotoxicity [23,26,49,56]. This 
notion  suggested  a  possible  relation  between  the  presence  of the γ-hydroxybutenolide moiety  and  
the cytotoxicity. 
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Petrosaspongiolides  A  (41)  and  B  (42)  were  the  first  cheilantane  sesterterpene  lactones  to  be 
isolated from a New Caledonian sponge incorrectly assigned to the genus Dactylospongia [57] and 
then reassigned as a new genus and a new species: Petrosaspongia nigra (Bergquist 1995 sp. nov., 
class Demospongiae; order Dictyoceratida; family Spongidae) [58].  
From another New Caledonian collection of the same sponge,  15 additional petrosaspongiolide 
congeners (C–R) were isolated [59,60].  
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From the chloroform extract of another Dictyoceratida sponge of the genus Spongia, 21-hydroxy 
derivatives  of  petrosaspongiolides  K  (44a)  and  P  (48a)  were  isolated  in  addition  to  four  other 
pyridinium alkaloids named spongidines A–D (51–54) [61]. Spongidines were found to be structurally 
related to petrosaspongiolide L (45) particularly in the presence of pyridine ring. 
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Petrosaspongiolides  A–L  were  subjected  to  in  vitro  cytotoxicity  assay  against  the  human 
bronchopulmonary  NSCLC-N6  carcinoma  cell  line.  They  revealed  IC50  values  ranging  between  
1.0–32.2 µ M [59]. Petrosaspongiolides C (43) and K (44) exhibited the highest potency with IC50 
values of 1.0 and 3.5 µ M, respectively. However, petrosaspongiolides A (41) and B (42) were the least 
cytotoxic congeners in vitro with IC50 values of 28 and 32.2 µ M, respectively, 41 inhibited tumoral 
proliferation in vivo at 20 mg/Kg without significant toxicity when tested on immunosuppressed rats 
carrying a bronchopulmonary tumor (NSCLC-N6) [59].  
Petrosasponiolides  M–R  (46–50)  revealed  the  presence  of  a  γ-hydroxybutenolide  moiety  and  a 
hemiacetal  function.  Due  to  these  structural  similarities  to  manoalide  (1),  petrosaspongiolides  
M–R have received special attention from the scientific community to study their inhibitory activity 
against  PLA2  from  different  resources  to  point  out  their  specificity.  Two  main  groups  of  PLA2 
enzymes have been reported [62], the secretory PLA2 (sPLA2 groups I, II, III, V, IX, and X with 
relatively small molecular weights) and the cytosolic PLA2 (cPLA2 groups IV, VI, VII, and VIII with 
higher molecular weights). Inhibition of specific PLA2 constitutes a potentially useful approach for 
treating  a  wide  variety  of  inflammatory  disorders  such  as  spetic  shock,  adult  respiratory  distress 
syndrome, arthritis, and acute pancreatitis [61].  
Petrosaspongiolides M–R (46–50) together with 21-hydroxy derivatives of petrosaspongiolides K 
(44a) and P (48a), and spongidines A–D (51–54) were tested on five different sPLA2s belonging to the 
groups I (Naja naja venom and porcine pancreatic enzymes), II (human synovial recombinant and rat 
air-pouch secretory enzymes), and III (bee venom enzyme) [60,61]. Mar. Drugs 2010, 8     
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Among petrosaspongiolide derivatives, 46 and 48a inhibited mainly human synovial PLA2 with 
IC50 values of 1.6 and 5.8 µ M, respectively, compared to manoalide (1) (IC50 = 3.9 µ M) [60,61]. 
Petrosaspongiolide M (46) also inhibited bee venom PLA2 enzyme with IC50 of 0.6 µ M, compared to 1 
(IC50 of 7.5 µ M) [60]. 
The  mechanism  of  action  of  petrosaspongiolides  M–R  (46–50)  as  anti-inflammatory  marine 
metabolites has been the topic for many research articles [63–68]. The covalent binding of 46 to bee 
venom  PLA2  has  been  investigated  by  mass  spectrometry  and  molecular  modeling.  The  mass 
increment observed was consistent with the formation of a Schiff base by reaction of a PLA2 amino 
group with the hemiacetal function at the C-25 atom of the petrosaspongiolide M γ-hydroxybutenolide 
ring [63]. The molecular mechanism of inactivating the bee venom and the human type IIA secretory 
PLA2s by petrosaspongiolides R (50) [67], and M (46) [68], respectively, has been investigated. In 
both  cases,  either  covalent  (imine  formation)  and/or  non-covalent  (van  der  Waals)  interactions 
contributed to the inhibitory activity against PLA2 enzymes [67,68]. Due to potent anti-inflammatory 
properties  of  petrosaspongiolides,  their  chemical  synthesis  has  been  interestingly  investigated. 
Recently,  the  first  enantioselective  synthesis  of  petrosaspongiolide  R  (50)  has  been  successfully 
performed [69]. 
3. Triterpenes (C30) 
Steroidal  triterpenes  were  the  first  marine  isoprenes  to  be  discovered  in  the  1930s.  Scientific 
interest  has  been  driven  towards  these  metabolites  due  to  the  isolation  of  biosynthetically 
unprecedented derivatives possessing a broad spectrum of bioactivity(ies). Marine triterpenoids have 
been  reported  from  various  marine  macroorganisms.  In  this  section,  we  survey  two  examples  of 
triterpenoidal metabolites namely isomalabaricane triterpenes and steroidal saponins obtained from 
marine sponges with particular attention being drawn to their pharmacological significance. 
3.1. Isomalabaricane triterpenes 
Malabaricol (55) is the chief triterpene constituent of a yellow pigment obtained from the wood of 
the terrestrial plant Ailanthus malabarica (family Simaroubaceae), after which the whole group of 
related compounds was named [70–72]. Malabaricane, the trivial name of this group of compounds, 
was  given  to  the  hydrocarbon  system  (3S
*,3aR
*,5aS
*,9aS
*,9bS
*)-3a,6,6,9a-tetramethyl-3-(1,5,9-
trimethyldecyl)perhydr-obenz[e]indene,  where  the  tricylic  nucleus  has  a  trans-anti-trans  ring  
junction [71,72]. 
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The malabaricanes are structurally characterized by a tricyclic triterpenoid core and a conjugated 
polyene  side  chain  [70–72],  whereas  the  isomalabaricane  skeleton  is  embedded  in  a  
4,4,8,10-tetramethyl-perhydrobenz[e]indene  with  a  trans-syn-trans  ring  junction,  that  leads  to  an 
unfavorable twist-boat conformation for the central ring [73,74]. 
Isomalabaricane  triterpenes  were  first  reported  from  a  Fijian  collection  of  the  sponge  Jaspis 
stellifera [73] and the Somalian marine sponge Stelletta sp. [74]. Since then, they have been isolated 
from several genera of marine sponges belonging to the order Astrophorida including members of the 
genera  Rhabdastrella  [75,80,82,86,93,94,96,100],  Stelletta  [77–79,85,88,92],  Jaspis 
[81,87,89,98,99,101,102], and Geodia [83,90,95]. 
Isomalabaricane triterpenoids having polyene conjugated functionality can be classified into three 
groups: (1) stelletins principally possessing the γ-pyrone functionality, which could be ring-opened in 
some of its congeners yielding the side chain with terminal free carboxylic acid and methyl moieties, 
(2) stelliferins oxygenated at C-22, and 3) globostellatic acids whose main feature is a carboxyl group 
at C-4. In addition to triterpenoids, the isomalabaricane core has been also recognized in some sesqui- 
and/or sesterterpenes. The isomalabaricane terpenoids were sometimes trivially named according to 
their sponge origin. 
Upon  light  exposure,  the  isomalabaricane-type  terpenes  readily  isomerize  at  the  C-13  position. 
Therefore, during isolation and characterization processes, they rapidly equilibrate into a 1:1 mixture 
of the 13E and 13Z isomers [78–80,88,89,98,99]. Nevertheless, these compounds continue to gain a 
great deal of attention because of their significant cytotoxic activity [79,89], whereas the nature of the 
natural isomer, either 13E or 13Z or both, is still unresolved. Recently it was reported that the 
1H NMR 
spectrum of a crude extract obtained from the fresh sponge Rhabdastrella aff. distinca (Hainan, the 
South China Sea) revealed that it mostly contained isomalabaricanes with the 13E-configuration (H-15 
of most derivatives appeared around 7.0 ppm). Thus, the 13Z isomers were suggested in this case to be 
formed through isomerization during the isolation and analytical procedures [86]. 
Stelletins  comprise  the  first  group  of  isomalabaricane-type  triterpenoids.  Stelletin  A  (56)  was 
recognized in 1981 as a yellow triterpenoidal pigment from the Fijian marine sponge Jaspis stellifera 
[73].  Later,  it  was  obtained  together  with  its  E  isomer,  stelletin  B  (57),  from  the  marine  sponge 
Stelletta  tenuis  collected  off  Hainan  Island,  China  [77].  Stelletin  A  (56)  revealed  significant 
cytotoxicity against murine leukemia P388 cell line with IC50 of 2.1 nM [77]. 
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Stelletin G (62), with an opened γ-pyrone and featuring terminal -COOH and -CH3 functionalities, 
was isolated together with 56 from J. stellifera [73]. Later, stelletins G (62) was reported from the 
Australian marine sponge Stelletta sp. together with stelletins E (60) and F (61) [78]. The E isomer of 
stelletin G (62) was isolated from the marine sponge Rhabdastrella globostellata collected from the 
South China Sea and it was given the trivial name rhabdastrellic acid–A (63) [75,76].  
Research  interests  have  been  intensively  driven  toward this  group  of triterpenoidal  derivatives, 
which led to the isolation of eight further stelletins C,D, and H–M [78–80,82,85] , in addition to  
22,23-dihydrostelletin D [81]. 
Rhabdastrellins A–F (64–69), along with stelletins L (70) and M (71), were obtained from the 
marine sponge Rhabdastrella aff. distinca collected from a coral reef off Hainan, in the South China 
Sea [86]. Four of the rhabdastrellins (64–67) exhibited a primary alcohol moiety at C-29 instead of a 
methyl  group  as  for  the  stelletins  and  the other  two rhabdastrellins  E (68)  and  F (69).  While  all 
rhabdastrellins and stelletins L and M share a hydroxyl group at C-3 instead of a carbonyl group as in 
other stelletins [86]. 
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The antiproliferative profile of stelletins A–F (56–61) has been examined at the National Cancer 
Institute (NCI, Australia) against 60 cell lines. Due to the rapid isomerization upon light exposure, 
stelletins were tested as isomeric pairs. Stelletin C(58)/D(59) pair was the most potent derivative with 
a mean panel GI50 of 0.09 µ M. The stelletin E(60)/F(61) pair was approximately 10-times less potent 
(mean GI50 of 0.98 µ M) [79].  
Apoptotic cell death is a stress response of cells to cytotoxic agents that might be executed either 
through  a  receptor-mediated  pathway  that  activates  caspase-8  or  through  a  receptor-independent Mar. Drugs 2010, 8     
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pathway that involves the cyclin-kinase inhibitors p53/p21. Both pathways lead to a translocation of 
pro-apoptotic  Bax protein to  the mitochondria, thereby resulting  in  a  dissipation of mitochondrial 
membrane potential, activation of caspase-3, and execution of the apoptotic machinery [84]. 
Stelletin  A  (56)  demonstrated  a  differential  cytotoxicity  against  human  leukemia  HL-60  cells  
(IC50  0.9  µ M)  compared  to  human  prostate  cancer  LNCaP  cells  (IC50  260  µ M)  by  activation  of 
NADPH oxidase, which induces oxidative cell death through a FasL–caspase-3-apoptotic pathway 
[83]. Stelletins B (57) and E (60) revealed selective cytotoxicity toward p21-deficient human colon 
tumor HCT-116 cells with IC50 values of 0.043 and 0.039 µ M, respectively [80]. Stelletins L (70) and 
M (71) exhibited selective cytotoxicity against stomach cancer AGS cells with IC50 values of 3.9 and 
2.1 µ M, respectively [85]. Rhabdastrellic acid–A (63) also inhibited proliferation of human leukemia 
HL-60 cells with an IC50 value of 1.5 µ M through inhibition of the PI3K/Akt pathway and induction of 
caspase-3 dependent-apoptosis [76]. Only rhabdastrellin A (64) possessed moderate inhibitory activity 
toward  human  leukemia  HL-60  cells  (IC50  =  8.7  µ M)  while  other  rhabdastrellins  were  inactive  
(IC50 > 20 µ M) [86]. 
Stelliferins are the second group of isomalabaricane triterpenes. To the best of our knowledge,  
13 compounds belonging to this group have been reported. In addition to stelliferins A–F (72–77), 
which have been isolated from the Okinawan marine sponge Jaspis stellifera [87], stelliferin G (78) 
and 29-hydroxy derivatives of stelliferins A (79) and E (80) have been isolated from an unidentified 
species of the genus Jaspis collected near Tonga [89]. 
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The 29-hydroxy derivative of stelliferin D (81) together with 3-epimeric isomers of 79 and 80 were 
reported from the marine sponge Stelletta globostellata collected by SCUBA off Mage-jima Island, 
Japan  [88].  Whereas  stelliferin  riboside  (72a),  the  first  example  of  a  glycosylated  stelliferin,  was 
isolated from the Fijian sponge Geodia globostellata [90]. Mar. Drugs 2010, 8     
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Stelliferins A–F (72–77) exhibited potent in vitro antineoplastic activities against murine lymphoma 
L1210 cells (IC50 of 1.1–5.0 µ M) and human epidermoid carcinoma KB cells (IC50 of 2.8–13.0 µ M) 
[87], while the isomeric mixture of stelliferin G (78) and 29-hydroxystelliferin A (79) showed the 
highest inhibitory activity against the melanoma MALME-3M cell line with IC50 values of 0.2 and  
0.4 µ M, respectively [89]. Stelliferin riboside (72a) displayed moderate cytotoxicity against ovarian 
A2780 cancer cells (IC50 = 60 µ M) [90]. 
Due  to  the  significant  antiproliferative  activity  exhibited  by  stelletins  and  stelliferins,  research 
efforts  have  been  directed  towards  their  chemical  synthesis.  In  1999,  Raeppel  et  al.  successfully 
synthesized the common trans-syn-trans perhydrobenz[e]indene moiety in the isomalabaricane-type 
terpenoids, which enabled the chemical synthesis of stelletins and stelliferins [91].  
 Globostellatic acid (82) is the prototype of the third group of isomalabaricane-type triterpenoids 
sharing carboxylation at C-4. It was first isolated together with three other derivatives, globostellatic 
acids B–D, from the marine sponge Stelletta globostellata collected off Mage Island near Kagoshima, 
Japan [92]. 
Other globostellatic acid congeners, F–M, and X methyl esters, have been reported from different 
collections of the Indonesian marine sponge Rhabdastrella globostellata [93,94]. 
Globostellatic  acids  revealed  potent  cytotoxicity  similar  to  the  stelletins  and  stelliferins. 
Globostellatic acids A–D demonstrated significant cytotoxicity against murine leukemia P388 cells 
with IC50 values of 0.2–0.8 µ M [92]. 
For cytotoxicity toward mouse lymphoma L5178Y cells, the 3-O-deacetyl congeners, globostellatic 
acids H/I (83/84) were the most active with an IC50 of 0.31 nM. However, acetylation of the C-3 
hydroxyl group decreases its bioactivity abruptly, as in globostellatic acids J/K (85/86), with an IC50 of 
8.28 nM. The reverse was found for the 13Z isomer of stelliferin riboside (72a) that revealed higher 
activity than its 3-O-deacetyl congener with IC50 values of 0.22 and 2.40 nM, respectively [93]. 
On the other hand, globostellatic acids showed only moderate or no cytotoxicity against either 
human cervix carcinoma HeLa or rat pheochromocytoma PC-12 cell lines [93]. Two globostellatic 
acid  X  methyl  esters  (87  and  88),  possessing  the  13E-geometry,  inhibited  proliferation  of  human 
umbilical vein endothelial cells (HUVECs), 80- to 250-fold greater in comparison to several other cell Mar. Drugs 2010, 8     
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lines  and  hence inhibiting  angiogenesis  which  if pathologically  uncontrolled, accompanies  several 
diseases such as atherosclerosis, arthritis, diabetic retinopathy, and cancer. 
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13E,17E-  Globostellatic  acid  X  methyl  ester  (87)  also  inhibited  basic  fibroblast  growth  factor 
(bFGF)-induced tubular formation and vascular endothelial growth factor (VEGF)-induced migration 
of HUVECs. In addition, 87 induced apoptosis of HUVECs without affecting their VEGF-induced 
phosphorylation of ERK1/2 kinases [94]. 
Geoditins, which are stelliferin-related isomalabaricane triterpenoids, are mainly oxygenated at both 
C-22 and C-25. Five geoditins (89–93) were obtained from the marine sponges Geodia japonica [95] 
and Rhabdastrella aff. distinca [96] collected at different locations in the South China Sea. 
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Geoditins (89–93) were submitted for bioassays against several human tumor cell lines including 
HL-60  (promyelocytic  leukemia),  PC-3MIE8  (prostate  carcinoma),  BGC-823  (gastric  carcinoma), 
MDA-MB-423  (breast  carcinoma),  Bel-7402  (hepatocellular  carcinoma)  and  HeLa  (cervical 
carcinoma) cells. Isogeoditin A (91) showed significant cytotoxicity towards the former three cell lines 
with IC50 values of 0.3, 0.2 and 1.0  µ M, respectively. While 13E-isogeoditin A (92) revealed no 
cytotoxic activity, implying that the Z-geometry at C-13 enhances antiproliferative activity compared 
to the E-form [96]. Geoditin A (89) proved to be cytotoxic against HL-60 cells [IC50 = 6.7 µ M)] while 
geoditin  B  (90)  exhibited  relatively  weak cytotoxicity.  Mechanistically,  geoditin  A (89)  markedly 
induced reactive oxygen species (ROS), decreased mitochondrial membrane potential and mediated a 
caspase-3 apoptosis pathway [97]. 
Jaspiferals (94–103) and aurorals (104–107) are isomalabaricane-type terpenoids differentiated into 
nortriterpenoids,  norsesterterpenoids  and  norditerpenes  possessing  a  3α-hydroxy  group.  Jaspiferals  
A–G  (94–100)  were  purified  from  the  Okinawan  marine  sponge  Jaspis  stellifera  [98]  while  the  
3-O-acetyl and methyl ester derivatives of jaspiferals B (101), D (102) and E (103) were obtained from 
a new species of Jaspis collected at the Vanuatu Islands [99]. Aurorals (104–107) have been isolated 
from the New Caledonian marine sponge Rhabdastrella globostellata [100]. 
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Jaspiferals A–G (94–100) exhibited in vitro cytotoxicity against murine lymphoma L1210 cells 
with  IC50  values  of  1.6–10.4  µ M,  whereas  only  jaspiferals  E–G  (98–100)  revealed  antineoplastic Mar. Drugs 2010, 8     
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activity against human epidermoid carcinoma KB cells (IC50 of 5.2–14.7 µ M) [98]. Jaspiferal G (100) 
exhibited  antifungal  activity  against  Cryptococcus  neoformans  (MIC,  144  µ M)  and  Trichophyton 
memtagrophytes (MIC, 36 µ M), and antibacterial activity against Sarcina lutea (MIC, 144 µ M), while 
the mixture of jaspiferals E (98) and F (99) showed antifungal activity against T. memtagrophyes 
(MIC, 134 µ M) [98]. On the other hand, the 3-O-acetyl, methyl ester derivatives of jaspiferals B (101), 
D (102) and E (103) revealed weak cytotoxicity against L1220 cells (IC50 > 8.8 µ M) [99]. 
Aurorals (104–107), which differ from jaspiferals C–F (96–99) by the presence of a primary alcohol 
group at the C-4 position, exhibited stronger cytotoxicity against KB cells. The isomeric mixtures of 
aurorals  (104/105),  (106/107)  and  jaspiferals  C/D  (96/97)  showed  IC50  values  of  0.5,  22.2  and  
13.3 µ M, respectively, while jaspiferals E/F (98/99) were inactive up to 27 µ M [100]. 
Jaspolides represent another example of isomalabaricane-type terpenoids of either monomeric or 
dimeric congeners. Monomeric congeners of jaspolides could be classified into triterpenes, jaspolides 
A (108) and B (109); sesterterpene, jaspolide F (113); diterpenes, jaspolides C (110) and D (111); and 
nortriterpene, jaspolide E (112) which were all isolated from the marine sponge Jaspis sp. collected 
from the South China Sea [101]. 
Figure 2. Proposed biogenetic transformation of jaspolides A–F (108–113) [101]. 
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A presumable biogenetic transformation scheme of jaspolides A–F (108–113) (Figure 2), revealed 
that light-induced isomerization is responsible for the jaspolides A/B (108/109) and C/D (110/111) 
isomeric  pairs.  In  addition  it  substantiated  jaspolide  D  (111)  as  a  precursor  to  jaspolide  F  (113), 
formed  through  condensation  with  an  isoprenyl  pyrophosphate  (IPP)  followed  by  oxidation  at  a 
terminal methyl group [101]. Jaspolides G (114) and H (115) are dimeric isomalabaricane congeners 
which were isolated from the same Chinese sponge Jaspis sp. and their proposed biogenetic pathway 
(Figure 3) suggested that they were derived from stelletin A (56) yielding the left moiety, and the 
nortriterpene, geoditin A (89) yielding the right moiety [102]. 
Jaspolide B (109) arrested HL-60 cells in the G2/M phase of the cell cycle and induced apoptosis in 
a  dose-  and  time-dependent  manner.  Jaspolide  B  with  an  IC50  value  of  0.61  µ M  exhibited  a 
comparable  efficacy  as  that  of  paclitaxel  (IC50  =  0.78  µ M).  These  results  suggested  109  to  be  a 
promising anticancer agent for chemotherapy of leukemia by prohibiting cell cycle progression at the 
G2/M phase and triggering apoptosis [103]. 
Figure 3. Postulated biogenetic pathway of jaspolides G (114) and H (115) [102]. 
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In a further study with human hepatoma cells, jaspolide B ( 109) inhibited the growth of Bel-7402 
and HepG2 cells with IC50 values of 29.1 and 29.5 µ M, respectively. Incubation with 0.5 µ M of 109 
caused  time-dependent  induction  of  apoptosis  in  Bel-7402  as  confirmed  by  the  enhancement  of 
mitochondrial  masses,  cell  membrane  permeability,  and  nuclear  condensation.  In  conclusion,  the 
anticancer effect of jaspolide B involves multiple mechanisms including apoptosis induction, cell cycle 
arrest, and microtubule disassembly but these were weaker than colchicine, a well-known microtubule-
disassembly  agent  [104].  These  multiple  mechanisms  of  jaspolide  B,  especially  the  apoptosis 
induction, pose interesting perspectives for further exploration of the isomalabaricane-type terpenes as 
potential anticancer agents. 
Since the class of isomalabaricane terpenoidal metabolites has been reported in the literature from 
different sponge species of the genera Rhabdastrella, Stelletta, Jaspis, and Geodia as shown above, the Mar. Drugs 2010, 8     
 
 
331 
identity  of  these  sponges  has  been  questioned  and  reevaluated.  Interestingly,  the  taxonomic 
reevaluation of these sponges revealed that they all might be reassigned to Rhabdastrella globostellata 
(class  Demospongiae;  order  Astrophorida;  family  Ancorinidae)  [80].  However,  it  could  not  be 
ascertained for the isomalabaricane producing Stelletta sp. from Somalia [74] and Stelletta tenuis from 
China  [77].  The  latter,  collected  from  an  identical  location  (Hainan  Island),  was  taxonomically 
recognized as R. globostellata [75]. 
3.2. Steroidal saponins 
In  the  Kingdom  Animalia,  steroidal  and  triterpene  glycosides  are  predominant  metabolites  of 
starfishes and sea cucumbers, respectively [108]. In addition, these types of glycosides have also been 
isolated  from  marine  sponges.  To  the  best  of  our  knowledge,  around  80  sponge  triterpenoidal 
glycosides  have  been  reported  to  date,  including  erylosides  [107–114],  formosides  [115,116], 
nobiloside  [117],  and  sokodosides  [118]  from  different  sponge  species  of  the  genus  Erylus; 
sarasinosides from the marine sponges Asteropus sarasinosum [120–123], Melophlus isis [124], and 
M. sarassinorum [125]; mycalosides from Mycale laxissima [126–128]; ectyoplasides and feroxosides 
from the Caribbean marine sponge Ectyoplasia ferox [129,130]; ulososides from Ulosa sp. [131,132]; 
wondosterols from a two-sponge association [133]; and pachastrelloside A from a marine sponge of 
the genus Pachastrella [134]. The majority of these glycosides belong to norlanostane-triterpenoidal 
saponins, derived from lanosterol or related triterpenes as a result of oxidative elimination of one or 
two methyl groups. 
Penasterol (116), an acidic steroidal metabolite closely related to lanosterol (117) and possessing 
potent antileukemic activity, was originally isolated from the Okinawan marine sponge Penares sp. in 
1988 [105]. Penasterol together with its analogs penasterone and acetylpenasterol, isolated from the 
Okinawan marine sponge Penares incrustans, inhibit IgE-dependent histamine release from rat mast 
cells [106]. 
Eryloside  A  (118)  was  the  first  eryloside  congener  isolated  from  the  Red  Sea  sponge  Erylus 
lendenfeldi (class Demospongiae; order Choristida; family Geodiidae) [107]. Twenty eight additional 
erylosides (A–F, F1–F7, G–V) have been reported from different species of the genus Erylus including 
E. goffrilleri [109,114], E. formosus [110,113], E. nobilis [111], in addition to another collection of E. 
lendenfeldi [112]. 
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For eryloside A (118), antitumor activity against murine leukemia P388 cells with an IC50 = 5.7 µ M 
and  antifungal  activity  against  Candida  albicans  (MIC  =  21.1  µ M)  have  been  reported  [107]. 
Eryloside E (119), glycosylated at C-30 through an ester linkage with the rare t-butyl substitution of 
the  side  chain,  was  isolated  from  an  Atlantic  sponge  Erylus  goffrilleri  [109].  It  revealed 
immunosuppressive  activity  with  an  EC50  of  1.8  µ M  and  a  therapeutic  index  (TI)  of  9.5,  which 
indicated  that  the  immunosuppressive  effect  is  specific  and  is  not  due  to  a  general  cytotoxic  
effect [109]. 
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Eryloside F (120) was reported from two collections of the marine sponge E. formosus [110] and 
exhibited potent thrombin receptor antagonistic activity. Furthermore, it inhibited platelet aggregation 
in vitro. Against hepytocyte HepG2 cells, 120 possessed little activity [110]. Erylosides F1 (121) and 
F3 (122) were isolated along with nine other congeners from the Caribbean sponge E. formosus [113]. 
In contrast to its 24-epimer, eryloside F3 (122) induced early apoptosis in Ehrlich carcinoma cells at 
130 µ M, while erylosides F (120) and F1 (121) activated the Ca
2+ influx into mouse spleenocytes at the 
same doses [113].  
Erylosides K (123) and L (124) have been obtained together with 118 from another collection of the 
Red Sea marine sponge Erylus lendenfeldi [112]. While 123 was identified as the 24,25-didehydro 
congener of eryloside A, eryloside L (124) incorporated a naturally unprecedented 8α,9α-epoxy-4α-
methyl-8,9-secocholesta-7,9(11),14-triene skeleton [112]. Erylosides A (118) and K (123) led to a 
50% mortality rate in the brine shrimp assay at a concentration of 0.14 mM. Whereas, eryloside L 
(124) was inactive at the same concentration [112].  
In addition to erylosides, the marine sponges E. formosus and E. nobilis produced other steroidal 
saponins  identified  as  formosides  A  (125)  [115]  and  B  (126)  [116];  and  nobiloside  (127)  [117], Mar. Drugs 2010, 8     
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respectively, whilst sokodosides A (128) and B (129) have been obtained from the marine sponge 
Erylus  placenta  [118].  A  convergent  synthesis  of  the  trisaccharides  of  129  has  been  successfully 
performed [119]. 
Formoside A (125) was first reported by Jaspars and Crews in 1994 from the Caribbean marine 
sponge Erylus formosus [115]. Later, it was isolated together with formoside B (126) from another 
collection  of  the  same  sponge  from  the  Bahamas  [116].  Formoside  A  (125)  and  its  N-acetyl 
galactosamine  derivative,  formoside  B  (126)  possess  deterrent  properties  against  predatory  fish. 
Therefore, they were suggested to have important ecological functions, resembling those ascribed to 
similar compounds present in sea stars, sea cucumbers, and terrestrial plants [116]. 
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Nobiloside (127), a penasterol saponin, was reported from the marine sponge E. nobilis collected 
off  Shikine-jima  Island,  Japan  [117]  and  revealed  the  presence  of  a  carboxylic  group  at  C-30  in 
addition  to  uronic  acid  moieties.  Nobiloside  (127)  inhibited  neuraminidase  from  the  bacterium 
Clostridium perfrigens with an IC50 of 0.5 µ M [117]. 
O
COOH
3
4
8
9
10
13
14
18
19
20
21 22 24
25
26
27
28 29
O
OH
1'
5'
2'
30
HO
O
OH
O
OH 1''
5'' O
OH
HO
OH
5'''
1'''
COOH COOH
-D-GlcU
O
-D-GalU -D-Ara  
127 
 
Sokodosides A (128) and B (129) were obtained from the marine sponge E. placenta collected off 
Hachijo Island, Japan [118]. They possessed a novel carbon skeleton as characterized by the presence 
of  a  combination  of  an  isopropyl  side  chain  and  the  4,4-dimethyl  steroid  nucleus.  Moreover, 
sokodoside B (129) exhibited double bonds at unusual positions ∆
8(9),14(15),16(17). 
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Both  sokodosides  displayed  moderate  antifungal  activity  against  the  fungus  Mortierella 
ramanniana  and  the  yeast  Saccharomyces  cereivisiae,  but  no  antibacterial  activity  was  found. 
Additionally, sokodosides A (128) and B (129) exhibited cytotoxic activity against P388 cells with 
IC50 values of 103 and 62 µ M, respectively [118]. 
Sarasinosides follow erylosides in the number of isolated metabolites. To date, 21 sarasinoside 
congeners have been reported, which all featured a carbonyl group at C-23 position. Sarasinoside A1 
(130) was the first steroidal saponin reported in the literature, even before eryloside A (118), from the 
Palauan marine sponge Asteropus sarasinsum, together with other eight new congeners [120–122]. 
Then, from the same sponge collected in the Solomon Islands, four additional sarasinosides D–G were 
reported [123]. From each of the marine sponges Melophlus isis (Guam) [124] and M. sarassinorum 
(Indonesia) [125], four sarasinoside congeners were isolated.  
Among the sarasinoside congeners known to date, sarasinoside A1 (130) and B1 (131) exhibited 
piscicidal  activity  against  Poecilia  reticulata  with  LD50  values  (48  h)  of  0.3  and  0.6  µ M,  
respectively [120,122].  
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Sarasinoside A1 is known to possess moderate cytotoxicity in vitro against leukemia P388 [121] and 
K562 [124] cell lines with IC50 values of 2.2 and 5.0 µ M, respectively. Sarasinoside A3, which differs 
from A1 (130) in having ∆
8(9),14(15) instead of ∆
8(9) unsaturation, exhibited mild cytotoxic activity with 
an IC50 of 13.3 µ M [124]. 
In the agar diffusion antimicrobial assay (10 µ g/disc), sarasinoside A1 showed strong and selective 
activity against the yeast S. cerevisiae but was inactive against B. subtilis and E. coli. On the other 
hand, sarasinoside J (132) was active against S. cerevisiae and showed moderate antibacterial activity 
against B. subtilis and E. coli [125]. 
Mycalosides  include  eleven  steroidal  saponin  congeners  that  were  isolated  from  the  Caribbean 
marine  sponge  Mycale  laxissima  (class  Demospongiae;  order  Poecilosclerida;  family  Mycalidae) 
collected near San-Felipe Island, Cuba [126–128]. They were all characterized by having oxygenated 
C-4, C-15, and C-21 positions. 
Mycaloside  A  (133)  and  G  (134)  as  well  as  the  total  glycoside  fraction  did  not  influence 
nonfertilized eggs and the developing embryo up to the 8-blastomere stage at concentrations of up to 
94.6 µ M. However, these compounds were effective as spermatostatics when preincubated for 15 min 
with sea urchin sperm with an EC50 of 3.04 µ M. The total glycoside fraction generated a less toxic 
effect (EC50 = 7.03 µ g/mL) [127]. 
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Ectyoplasides A (135) and B (136) were first isolated from the Caribbean sponge E. ferox (class 
Demospongiae;  order  Axinellida;  family  Raspaliidae)  collected  along  the  coasts  of  San  Salvador 
Island,  Bahamas  [129].  The  compounds  are  C-4  norpenasterol  triterpenoidal  derivatives.  Later, 
ectyoplasides were reisolated together with feroxosides A (137) and B (138) from the same sponge 
collected along the coasts of Grand Bahama Island [130]. Feroxosides have been shown to be unusual 
C-4 norlanostane triterpenes glycosylated with a rhamnose-containing tetrasaccharide chain. 
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Against murine fibrosarcoma WEHI164, murine leukemia P388, and murine monocyte-macrophage 
J774 cell lines, both ectyoplasides (135 and 136) exhibited moderate in vitro cytotoxic activity with 
IC50 values ranging from 9.0 to 11.4 µ M [129], whilst against the latter cell line, feroxosides (137 and 
138) were mildly cytotoxic (IC50 = 17.6 µ M) [130]. 
Pachastrelloside  A (139)  was obtained from the marine sponge  Pachastrella  sp. (Kagami Bay, 
Japan)  and  revealed  the  presence  of  a  cholest-5,24-diene-2α,3β,4β,7α-tetraol  aglycone  that  was 
glycosylated at the C-4 and C-7 positions with β-D-xylopyranose and β-D-galactopyranose moieties, 
respectively [134].  
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A Korean sponge-association composed of Poecillastra wondoensis and Jaspis wondoensis resulted 
in  the  isolation  of  wondosterols  A–C  (140–142),  which  are  structurally  related  to  139  [133]. 
Wondosterols were shown to have a β-OH group at C-7 and they were all diglycosylated at C-3 with  
β-D-xylopyranose connected to β-D-galactopyranose. 
Wondosterols A–C (140–142) were weakly cytotoxic against P388 cells (IC50 = 63 µ M) and at a 
concentration of 10 µ g/disk only 140 and 142 showed antibacterial activities against P. aeruginosa and 
E.  coli  [133].  Pachastrelloside  A  (139)  inhibited  cell  division  of  fertilized  starfish  (Asterina 
pectinifera) eggs at 35 µ M [134]. Mar. Drugs 2010, 8     
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4. Future Aspects 
The enormous diversity of marine natural products combined with improved global concerns to find 
new therapeutic agents for the treatment of different ailments provide the stimulus to evaluate marine 
natural products in clinical trials. Marine drug discovery faces many obstacles including a sufficient 
supply, and the low concentrations of some compounds that may account for less than 10
-6% of the wet 
weight [135]. However, there have been substantial advances, suggesting that sustainable sourcing 
could be achievable. Since the continuous and exhaustive harvesting of terrestrial drug lead resources 
proved to be unreliable and resulted in the frequent re-isolation of known compounds, researchers 
from academia and from pharmaceutical companies alike are now turning their focus to the sea in 
search for new lead structures from nature. Nevertheless, the large scale production of marine natural 
products for clinical use is a real challenge, and therefore environmentally sound and economically 
feasible alternatives are required. 
Chemical synthesis is among the first strategies to be explored, but unfortunately the structural 
complexity of marine metabolites with novel mechanisms of action and high selectivity has resulted in 
only a few successful examples with this strategy such as the conus toxin ziconotide [136]. A second 
strategy, but also as labor-intensive, is to study the pharmacological significance of marine natural 
product  pharmacophores  and  then  attempt  to  define  the  critical  pharmacophore  that  can  result  in 
practical drugs based on a marine prototype via chemical synthesis, degradation, modification or a 
combination of these. 
Aquaculture of the source organisms, including sponges, tunicates, and bryozoans, with an aim at 
securing  a  sustainable  supply  of  the  active  constituent(s),  has  progressed  notably  in  cancer 
applications. However, in most cases the biomass currently generated is still far from that required, 
should a marine-based drug finally enter the pharmaceutical market [137]. Furthermore, the cultivation 
of  invertebrates  in  their  natural  environment  is  subject  to  several  hazards  and  threats,  such  as 
destruction by storms or diseases. An intriguing strategy has been to identify the true producers of 
bioactive compounds and to explore whether or not they are of microbial origin including bacteria, 
cyanobacteria, or fungi that are known to harbour within the tissues of marine invertebrates. 
If bacterial or other associated microorganisms proved to produce the compounds of interest, a 
careful design of special culture media would be crucial for large-scale fermentation e.g., ET-743 
production. Currently, only 5% or less of the symbiotic bacteria present in marine specimens can be 
cultivated  under  standard  conditions  [138].  Consequently,  molecular  approaches  offer  particularly 
promising alternatives through the transfer of biosynthetic gene clusters to a vector suitable for large-
scale fermentation, thereby avoiding the obstacles in culturing symbiotic bacteria. 
Oceans will play a potential role in the future to control and relieve the global disease burden. In 
spite of the substantial development that has been achieved in disclosing novel drug leads from marine 
resources, more efforts are still required for more chemical entities to reach to clinical applications. 
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